Risk factors for severe outcomes in people with diabetes hospitalised for COVID-19: a cross-sectional database study

Author:

Ortega Emilio,Corcoy Rosa,Gratacòs Mònica,Cos Claramunt Francesc Xavier,Mata-Cases ManelORCID,Puig-Treserra Ramon,Real Jordi,Vlacho Bogdan,Castelblanco EsmeraldaORCID,Domingo Pere,Khunti Kamlesh,Franch-Nadal Josep,Mauricio DidacORCID

Abstract

AimThis study’s objective was to assess the risk of severe in-hospital complications of patients admitted for COVID-19 and diabetes mellitus (DM).DesignThis was a cross-sectional study.SettingsWe used pseudonymised medical record data provided by six general hospitals from the HM Hospitales group in Spain.Outcome measuresMultiple logistic regression analyses were used to identify variables associated with mortality and the composite of mortality or invasive mechanical ventilation (IMV) in the overall population, and stratified for the presence or absence of DM. Spline analysis was conducted on the entire population to investigate the relationship between glucose levels at admission and outcomes.ResultsOverall, 1621 individuals without DM and 448 with DM were identified in the database. Patients with DM were on average 5.1 years older than those without. The overall in-hospital mortality was 18.6% (N=301), and was higher among patients with DM than those without (26.3% vs 11.3%; p<0.001). DM was independently associated with death, and death or IMV (OR=2.33, 95% CI: 1.7 to 3.1 and OR=2.11, 95% CI: 1.6 to 2.8, respectively; p<0.001). In subjects with DM, the only variables independently associated with both outcomes were age >65 years, male sex and pre-existing chronic kidney disease. We observed a non-linear relationship between blood glucose levels at admission and risk of in-hospital mortality and death or IMV. The highest probability for each outcome (around 50%) was at random glucose of around 550 mg/dL (30.6 mmol/L), and the risks flattened above this value.ConclusionThe results confirm the high burden associated with DM in patients hospitalised with COVID-19 infection, particularly among men, the elderly and those with impaired kidney function. Moreover, hyperglycaemia on admission was strongly associated with poor outcomes, suggesting that personalised optimisation could help to improve outcome during the hospital stay.

Funder

Primary Care Diabetes Europe

Publisher

BMJ

Subject

General Medicine

Reference46 articles.

1. World Health Organization . 15-Novel Coronavirus(2019-nCoV). WHO Bull 2020:1–7.

2. Agència de Salut Pública de Catalunya (ASPCAT) . Informe tècnic resum dels casos de covid-19 a Catalunya, 2020. Available: http://salutpublica.gencat.cat/web/.content/minisite/aspcat/butlletins/vigilanciaaspcat/2020/45/INFORME-TECNIC-3-COVID-19_020420.pdf

3. Linde P . Sanidad confirma en La Gomera El primer caso de coronavirus en España. El País. ISSN 1134-6582, February 1, 2020. Available: https://elpais.com/sociedad/2020/01/31/actualidad/1580509404_469734.htm

4. COVID-19 pandemic, coronaviruses, and diabetes mellitus;Muniyappa;Am J Physiol Endocrinol Metab,2020

5. Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: a systematic review and meta-analysis;Zhou;Int J Infect Dis,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3